- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07284108
Healthy Eating for My Infant: A Community- Informed Infant Obesity Prevention Program Addressing the Impact of Maternal Mental Health on Eating and Feeding
December 12, 2025 updated by: Cathy Stough, University of Cincinnati
Feasibility, Acceptability, and Preliminary Phase II Efficacy Testing of a Community-Informed Infant Obesity Prevention Program Addressing the Impact of Maternal Mental Health on Eating and Feeding.
Infants from low-income families are at increased risk for obesity, but obesity prevention programs tailored specifically to the needs of these infants are lacking.
Our team developed Healthy Eating for My Infant (HEMI) to address the specific obesity risk factors, barriers to health behaviors, and needs articulated by community members and low-income families (e.g., maternal mental health, realistic feeding options within the context of food insecurity).
The current study will examine the feasibility and acceptability of HEMI delivered via home visiting, as well as preliminary efficacy for improving infant growth trajectories, diet, and parenting/feeding factors related to future obesity risk among infants from low-income families.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Cathy Stough, PhD
- Phone Number: 15135565589
- Email: odarcc@ucmail.uc.edu
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45220
- University of Cincinnati
-
Contact:
- Cathy Stough, PhD
- Phone Number: 513-556-5589
- Email: odarcc@ucmail.uc.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria
- Child age 2 months 0 days to 2 months 30 days at baseline.
- Child is a singleton.
- Mom's must be fluent in English or Spanish.
- Mom must be 18 years or older.
Exclusion Criteria
- Child has major congenital abnormalities or medical conditions requiring specialized feeding.
- Family is currently enrolled in home grocery delivery.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Participants randomized into this arm will not receive the study intervention.
They will continue to receive standard home visiting services through Every Child Succeeds.
|
|
|
Experimental: Intervention
Participants randomized into this arm will receive the Healthy Eating for My Infant Intervention (HEMI).
|
Our team developed an obesity prevention program, Healthy Eating for My Infant (HEMI), to address the unique factors influencing obesity risk and health behaviors among low-income families and their infants and to be delivered in conjunction with an existing evidence-based home visiting program.
HEMI targets healthy feeding with children 3-14 months old through twice monthly behavioral and educational sessions alongside sessions with a peer counselor with similar lived experience to mothers in the program.
HEMI incorporates education and evidence-based behavioral techniques (e.g., problem solving, goal setting, behavioral rehearsal) to address topics such as infant nutrition, introduction of solid foods, responsive feeding, realistic healthy eating options, healthy eating on a budget, and recipes).
All sessions are delivered in the families' homes.
The intervention also includes free grocery delivery and supplemental funds for purchasing foods through grocery delivery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant Retention
Time Frame: Immediately after the intervention (post-treatment study visit), 6 months after completion of the post-treatment study visit (6 month follow-up visit)
|
Participant retention is defined as the percentage of participants that complete each study visit.
The percentage of participants completing the post-treatment measurement visit and the 6-month follow-up visit will be calculated, and separate percentages will be calculated for each arm of the study (i.e., control, intervention).
This will be measured by tracking yes or no for whether each study visit is completed for each participant.
|
Immediately after the intervention (post-treatment study visit), 6 months after completion of the post-treatment study visit (6 month follow-up visit)
|
|
Treatment Session Completion
Time Frame: Between child age 3 months-14 months (the time period during which the intervention condition is receiving the program).
|
The percentage of treatment sessions completed within the designated completion windows will be monitored.
|
Between child age 3 months-14 months (the time period during which the intervention condition is receiving the program).
|
|
Treatment Acceptability
Time Frame: Between child age 3 months-14 months (the time period during which the intervention condition is receiving the program), Immediately after the intervention (post-treatment study visit)
|
Families, peer counselors, and health behavior coaches delivering the program will evaluate program acceptability, utilizing the theoretical framework of acceptability.
Families will complete an established questionnaire assessing components of the TFA: affective attitude and effectiveness, coherence and understanding, and perceived burden.
The established questionnaire will also be modified to be completed by peer counselors and health behavior coaches to report their perception of acceptability of the program for families.
Qualitative interviews will also be conducted with families, peer counselors, and health behavior coaches to identify any modifications to the HEMI program to improve acceptability.
|
Between child age 3 months-14 months (the time period during which the intervention condition is receiving the program), Immediately after the intervention (post-treatment study visit)
|
|
Body Mass Index
Time Frame: Between child ages 3-14 months (when the intervention condition is receiving the program), Immediately after the intervention (post-treatment study visit), 6 months after completion of the post-treatment study visit (6 month follow-up visit).
|
Anthropometrics will be measured in triplicate using a calibrated mobile digital SECA baby scale and portable infant length board.
Infants will be weighed in a clean diaper without clothes to the nearest 1 gram.
The length board has a stable headboard and a moveable foot piece and will be placed on a flat, hard surface.
All length measurements will be performed by two team members, with one holding the infant's head straight and flush against the headboard, while the other places one hand across the knees to fully straighten and extend the legs so that heels are at a 90-degree angle against the foot piece and reads the measurement.
If holding both legs is not possible, the measurement can be taken with only the right leg extended.
|
Between child ages 3-14 months (when the intervention condition is receiving the program), Immediately after the intervention (post-treatment study visit), 6 months after completion of the post-treatment study visit (6 month follow-up visit).
|
|
Diet Variety
Time Frame: Immediately after the intervention (post-treatment study visit), 6 months after completion of the post-treatment study visit (6 month follow-up visit).
|
Child diet will be assessed via three 24-hour dietary recall interviews conducted with mothers by phone.
Trained interviewers, blinded to participant study condition, will employ the USDA automated multiple-pass method, a standardized interview approach demonstrated to improve accuracy of dietary intake data.
Data from dietary recalls will be used to calculate diet variety using the minimum dietary diversity (MDD) approach.
|
Immediately after the intervention (post-treatment study visit), 6 months after completion of the post-treatment study visit (6 month follow-up visit).
|
|
Diet Quality
Time Frame: Immediately after the intervention (post-treatment study visit), 6 months after completion of the post-treatment study visit (6 month follow-up visit).
|
Child diet will be assessed via three 24-hour dietary recall interviews conducted with mothers by phone.
Trained interviewers, blinded to participant study condition, will employ the USDA automated multiple-pass method, a standardized interview approach demonstrated to improve accuracy of dietary intake data.
The Nutrition Data Systems for Research (NDSR; Nutrition Coordinating Center, University of Minnesota, Minneapolis, MN) software and foods database will be used to assess total daily energy and macronutrient intake as well as food group servings consumed.
Data from dietary recalls will be used to calculate diet quality using the Healthy Eating Index (HEI-Toddlers-2020) for children under age 2 years.
|
Immediately after the intervention (post-treatment study visit), 6 months after completion of the post-treatment study visit (6 month follow-up visit).
|
|
Food Security
Time Frame: Baseline, immediately after the intervention (post-treatment study visit), 6 months after completion of the post-treatment study visit (6 month follow-up visit).
|
Food security will be reported using the U.S. Household Food Security Survey Module: Short Form.
|
Baseline, immediately after the intervention (post-treatment study visit), 6 months after completion of the post-treatment study visit (6 month follow-up visit).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
January 1, 2026
Primary Completion (Estimated)
April 1, 2028
Study Completion (Estimated)
April 1, 2028
Study Registration Dates
First Submitted
November 26, 2025
First Submitted That Met QC Criteria
December 12, 2025
First Posted (Actual)
December 16, 2025
Study Record Updates
Last Update Posted (Actual)
December 16, 2025
Last Update Submitted That Met QC Criteria
December 12, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R01DK142998-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
In this proposed project, the raw participant-level data will be shared, along with derived metrics and transformations from initial raw data, with the exception of dietary intake data which will be available after processing by NDSR for nutrient and food servings information.
Data will be made available in .csv
format or other open file formats and will not require the use of specialized tools to be accessed or manipulated.
In accordance with FAIR Principles for data, we will use open file formats (e.g., JPEG, MP4, CSV, TXT, PDF, HTML, etc.) and persistent unique identifiers (PIDs).
IPD Sharing Time Frame
Scientific data will be shared as soon as possible.
Scientific data included in published manuscripts will be available at the time of publication; all other generated scientific data will be shared no later than the end of the award.
The study data will be stored in the repository for at least 5 years.
IPD Sharing Access Criteria
All datasets and other information that can be shared will be deposited in UCFigshare, a University of Cincinnati (UC) data repository for NIH-sponsored research at UC. UCFigshare is a platform for accessible and interoperable data sharing and available publicly at https://uc.figshare.com/.
Data and other information can be uploaded by NIH-sponsored UC researchers to promote sharing of scientific data in compliance with NIH policy for data management and sharing.
UCFigshare provides a data sharing platform consistent with the FAIR (Findability, Accessibility, Interoperability, and Reusability) data principles and is provided via a partnership between the UC Office of Research, UC Libraries, and DTS.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity & Overweight
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
National Taiwan University HospitalCompleted
-
PfizerNot yet recruitingObesity | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Overweight or Obesity | Overweight and/or Obesity | Nutritional and Metabolic DiseasesUnited States
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasRecruitingPediatric Obesity | Pediatric Overweight | Overweight , ObesityUnited States
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
-
University of British ColumbiaTerminatedOverweight and ObesityCanada
Clinical Trials on Healthy Eating for My Infant (HEMI)
-
University of CincinnatiCompleted
-
Université de SherbrookeRecruitingPregnancy Complications | Overweight and Obesity | Health Behavior | Life Style | Preconception CareCanada
-
Karolinska InstitutetCompletedType 2 Diabetes Mellitus | Dietary HabitsSweden
-
State University of New York at BuffaloNational Institute of Nursing Research (NINR); Roswell Park Cancer InstituteCompleted
-
State University of New York at BuffaloNational Institute of Nursing Research (NINR)Completed
-
Federal University of Health Science of Porto AlegreWithdrawn
-
Athabasca UniversityCompletedDiabetes Mellitus Gestational Previous PregnancyCanada
-
Stanford UniversityNational Cancer Institute (NCI)CompletedBreast Cancer | InsomniaUnited States
-
University College CorkActive, not recruiting
-
Supplement Formulators, Inc.CompletedBody WeightUnited States